Related Articles:

  1. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
    Facon T, et al. The Lancet, 2022, Sponsored by Janssen
  2. DSM-5 may split sexual disorders, gender identification
    Healio
  3. Sexual Disorders
    Richard Balon, World Scientific Book
Powered by
  • Targeting settings
  • Do not sell my personal information
  • Google Analytics settings
I consent to the use of Google Analytics and related cookies across the TrendMD network (widget, website, blog). Learn more